Article Text

Download PDFPDF
One step closer to African swine fever vaccine

Statistics from

By Josh Loeb

Scientists at the Pirbright Institute have taken an important step towards developing a vaccine for African swine fever (ASF).

In the global race to develop a prospective commercial vaccine, the Pirbright team has created a vectored vaccine and used it to successfully immunise pigs against a lethal dose of the ASF virus.

Publishing their research findings in the journal Vaccines, the team at the Surrey-based institute explained that they created the vaccine by inserting eight strategically selected ASF virus genes into a non-harmful virus.

This non-harmful virus delivers the genes into a pig’s cells, prompting the animal to produce virus proteins …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.